HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$14.40−0.33 (-2.24%)
Close on Nov 17, 2026Market cap $2.51BP/E 5.5Yield –
HUTCHMED (China) total assets
Total assets on the balance sheet at the end of each period.
HUTCHMED (China)'s total assets was $1.74B at Jun 30, 2026. For fiscal 2025 it was $1.75B, up 37.6% from the year before. Over ten years it grew 22.5% a year on average. The highest annual figure on record is $1.75B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.75B | +37.6% |
| FY2024 | Dec 31, 2024 | $1.27B | -0.4% |
| FY2023 | Dec 31, 2023 | $1.28B | +24.3% |
| FY2022 | Dec 31, 2022 | $1.03B | -25.0% |
| FY2021 | Dec 31, 2021 | $1.37B | +89.6% |
| FY2020 | Dec 31, 2020 | $724.12M | +55.7% |
| FY2019 | Dec 31, 2019 | $465.12M | -12.6% |
| FY2018 | Dec 31, 2018 | $532.12M | -11.0% |
| FY2017 | Dec 31, 2017 | $597.93M | +74.6% |
| FY2016 | Dec 31, 2016 | $342.44M | +49.1% |
| FY2015 | Dec 31, 2015 | $229.60M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.74B | +37.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.75B | +37.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.78B | +36.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.27B | +23.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.26B | +5.6% |
| Q4 FY2023 | Dec 31, 2023 | $1.28B | -6.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.30B | +1.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.03B | +42.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.19B | +127.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.37B | +195.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.27B | +180.3% |
| Q4 FY2020 | Dec 31, 2020 | $724.12M | +46.2% |
| Q2 FY2020 | Jun 30, 2020 | $525.56M | -2.5% |
| Q4 FY2019 | Dec 31, 2019 | $465.12M | -12.6% |
| Q3 FY2019 | Sep 30, 2019 | $454.09M | -21.4% |
| Q2 FY2019 | Jun 30, 2019 | $495.21M | -17.2% |
| Q1 FY2019 | Mar 31, 2019 | $539.30M | +56.5% |
| Q4 FY2018 | Dec 31, 2018 | $532.12M | +55.4% |
| Q2 FY2018 | Jun 30, 2018 | $577.94M | +151.7% |
| Q4 FY2017 | Dec 31, 2017 | $597.93M | – |
| Q2 FY2017 | Jun 30, 2017 | $344.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $342.44M | – |
| Q4 FY2015 | Dec 31, 2015 | $229.60M | – |
See a number that looks wrong?